PanAmerican Clinical Research - Cuernavaca

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials
• Metastatic breast cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Enrolling by invitation1 trial
• Terminated1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• EQRx, Inc.1 trial

Running trials

• Enrolling by invitation

  A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT05735483· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT05559359· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atopic dermatitis (eczema)1 recruiting

Closed trials

• Terminated

  A Study of Lerociclib in Participants With Advanced Breast Cancer

  NCT05085002· Phase 2· EQRx, Inc.· Source